Moreover, GSEA findings indicate that elevated CD74 expression is linked to the activation of a range of immune responses in breast cancer, including IFN-α and IFN-γ responses, and the IL6-JAK-STAT3 pathway. This evidence concerns the gene CD74 and breast carcinoma.